DarioHealth (DRIO) to Release Earnings on Thursday

DarioHealth (NASDAQ:DRIO) is anticipated to release its earnings data before the market opens on Thursday, March 27th. Analysts expect DarioHealth to post earnings of ($0.24) per share and revenue of $7.39 million for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

DarioHealth Stock Performance

NASDAQ DRIO opened at $0.72 on Thursday. The company has a market capitalization of $29.93 million, a price-to-earnings ratio of -0.77 and a beta of 1.42. DarioHealth has a twelve month low of $0.56 and a twelve month high of $1.93. The stock has a fifty day simple moving average of $0.69 and a 200 day simple moving average of $0.81. The company has a quick ratio of 1.32, a current ratio of 1.57 and a debt-to-equity ratio of 0.35.

Analyst Upgrades and Downgrades

DRIO has been the subject of a number of recent analyst reports. Stifel Nicolaus decreased their price target on DarioHealth from $3.50 to $2.00 and set a “buy” rating for the company in a report on Tuesday, March 11th. TD Cowen downgraded DarioHealth from a “buy” rating to a “hold” rating and decreased their price target for the stock from $2.00 to $1.00 in a report on Wednesday, January 29th.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.